Geneos Wealth Management Inc. lessened its stake in RTX Co. (NYSE:RTX – Free Report) by 3.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,711 shares of the company’s stock after selling 390 shares during the quarter. Geneos Wealth Management Inc.’s holdings in RTX were worth $1,471,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. MidAtlantic Capital Management Inc. purchased a new position in RTX during the 3rd quarter worth $29,000. Modus Advisors LLC bought a new stake in RTX in the 4th quarter worth about $39,000. Western Pacific Wealth Management LP purchased a new stake in RTX in the 3rd quarter valued at about $41,000. Kimelman & Baird LLC bought a new position in shares of RTX during the 2nd quarter worth approximately $46,000. Finally, ORG Wealth Partners LLC purchased a new position in shares of RTX in the 3rd quarter worth approximately $50,000. Hedge funds and other institutional investors own 86.50% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on RTX shares. Wells Fargo & Company boosted their price objective on RTX from $140.00 to $151.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. UBS Group increased their price target on shares of RTX from $126.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd. Susquehanna lowered their price objective on shares of RTX from $150.00 to $139.00 and set a “positive” rating on the stock in a research report on Wednesday, January 8th. Royal Bank of Canada raised shares of RTX from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $130.00 to $140.00 in a research report on Thursday, December 19th. Finally, Barclays lifted their price target on shares of RTX from $108.00 to $130.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 29th. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $158.27.
RTX Trading Down 0.8 %
Shares of RTX stock opened at $125.23 on Monday. The company’s 50-day moving average price is $118.38 and its 200-day moving average price is $118.54. The company has a market cap of $166.69 billion, a price-to-earnings ratio of 35.78, a PEG ratio of 1.99 and a beta of 0.81. RTX Co. has a 12-month low of $88.90 and a 12-month high of $128.70. The company has a current ratio of 0.99, a quick ratio of 0.73 and a debt-to-equity ratio of 0.62.
RTX Profile
RTX Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers in the United States and internationally. It operates through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The Collins Aerospace Systems segment offers aerospace and defense products, and aftermarket service solutions for civil and military aircraft manufacturers and commercial airlines, as well as regional, business, and general aviation, defense, and commercial space operations.
Read More
- Five stocks we like better than RTX
- The Risks of Owning Bonds
- MP Materials: Rare Earth Elements Powering the EV Boom
- 3 Stocks to Consider Buying in October
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How is Compound Interest Calculated?
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding RTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTX Co. (NYSE:RTX – Free Report).
Receive News & Ratings for RTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTX and related companies with MarketBeat.com's FREE daily email newsletter.